LLY

890.27

+1.4%↑

JNJ

241.35

+0.45%↑

ABBV

211.76

+0.99%↑

NVS

149.7

+0.98%↑

MRK

121.04

+1.14%↑

LLY

890.27

+1.4%↑

JNJ

241.35

+0.45%↑

ABBV

211.76

+0.99%↑

NVS

149.7

+0.98%↑

MRK

121.04

+1.14%↑

LLY

890.27

+1.4%↑

JNJ

241.35

+0.45%↑

ABBV

211.76

+0.99%↑

NVS

149.7

+0.98%↑

MRK

121.04

+1.14%↑

LLY

890.27

+1.4%↑

JNJ

241.35

+0.45%↑

ABBV

211.76

+0.99%↑

NVS

149.7

+0.98%↑

MRK

121.04

+1.14%↑

LLY

890.27

+1.4%↑

JNJ

241.35

+0.45%↑

ABBV

211.76

+0.99%↑

NVS

149.7

+0.98%↑

MRK

121.04

+1.14%↑

Home・Aandelen Lijst・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Gesloten

SectorGezondheidszorg

30.29 -4.84

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

30.09

Max

30.52

Belangrijke statistieken
By Trading Economics
Inkomsten	-14M -81M
Verkoop	75K 75K
EPS	-1.22
Winstmarge	-108,422.667
Werknemers	198
EBITDA	-7.8M -81M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+77.92% upside

Dividenden
By Dow Jones
Volgende Winsten	6 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	501M 2.1B
Vorige openingsprijs	35.13
Vorige sluitingsprijs	30.29

Nieuwssentiment

By Acuity

100%

322 / 349 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

18.91 / 20.63 Steun & Weerstand

Celldex Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

27 mrt 2026, 17:33 UTC

Belangrijke Nieuwsgebeurtenissen

ECB Should Not Rush Its Response to Iran Conflict, Says Schnabel -- Update

27 mrt 2026, 17:00 UTC

Belangrijke Nieuwsgebeurtenissen

ECB Shouldn't Rush Its Response to Iran Conflict, Schnabel Says

27 mrt 2026, 16:03 UTC

Belangrijke Nieuwsgebeurtenissen

Fertilizer Maker Yara Warns Farmers Are Being Squeezed by Price Surge Amid War -- Commodities Roundup

29 mrt 2026, 23:47 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Falls Amid Rising Inflation Fears -- Market Talk

29 mrt 2026, 23:46 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Nikkei May Fall on Fears About Shortage of Petrochemical Products -- Market Talk

29 mrt 2026, 23:35 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Rises on Supply-Disruption Concerns Spurred by Widening Mideast Conflict -- Market Talk

29 mrt 2026, 23:23 UTC

Marktinformatie

Australia's National Cabinet to Avoid Covid-Style Measures -- Market Talk

29 mrt 2026, 22:34 UTC

Marktinformatie

Macroeconomic Tailwind for Warehouse Dissipates -- Market Talk

29 mrt 2026, 22:09 UTC

Marktinformatie

Amplitude's Next Well "Effectively a Must-Win" for Growth Thesis -- Market Talk

29 mrt 2026, 21:06 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Australia's Economy Could Already Be Contracting Amid Oil Shock -- Market Talk

29 mrt 2026, 21:03 UTC

Marktinformatie

Australia's Government Wants to Avoid Heavy Handed Oil Shock Response -- Market Talk

29 mrt 2026, 21:01 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Australian National Cabinet Meeting to Focus on Oil Supply -- Market Talk

29 mrt 2026, 09:30 UTC

Acquisities, Fusies, Overnames

Food Mega-Mergers Hardly Ever Work. Could McCormick-Unilever Be Different? -- Heard on the Street -- WSJ

28 mrt 2026, 08:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

27 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

27 mrt 2026, 19:16 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Rise On Uncertainty Ahead of Weekend -- Market Talk

27 mrt 2026, 19:07 UTC

Marktinformatie

U.S. Natural Gas Gains As April Contract Expires -- Market Talk

27 mrt 2026, 19:04 UTC

Marktinformatie

Gold Rises But Can't Finish the Week Positive -- Market Talk

27 mrt 2026, 19:03 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Forex and Fixed Income Roundup: Market Talk

27 mrt 2026, 19:02 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Among Central Banks, Canada Has Room to Handle Oil Inflation -- Market Talk

27 mrt 2026, 18:12 UTC

Marktinformatie

Foreign Fuels and Feedstocks to Get RINs Until 2028 -- Market Talk

27 mrt 2026, 17:36 UTC

Belangrijke Nieuwsgebeurtenissen

The Iran War and Oil Prices Bring Risk of Deeper Market Lows. There Are Echoes of 2008. -- Barrons.com

27 mrt 2026, 17:34 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Delivery Hero Shares Bounce as Stake-Sale Report Whets Investor Appetites -- Market Talk

27 mrt 2026, 17:29 UTC

Marktinformatie

U.S. Oil Rig Count Falls By 5 to 409 -- Market Talk

27 mrt 2026, 16:38 UTC

Marktinformatie

Carnival's Outlook Assumes Oil Prices Will Come Down -- Market Talk

27 mrt 2026, 16:32 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Chinese Exposure to Higher Energy Costs Seen as Limited -- Market Talk

27 mrt 2026, 16:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

27 mrt 2026, 15:43 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Hormuz Closure Sends Tanker Rates to Record Highs -- Market Talk

27 mrt 2026, 15:25 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

27 mrt 2026, 15:25 UTC

Marktinformatie

Swiss Franc Dented by Rising European Yields, SNB Intervention Threats -- Market Talk

Peer Vergelijking

Prijswijziging

Celldex Therapeutics Inc Prognose

Koersdoel

By TipRanks

77.92% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 53.91 USD 77.92%

Hoogste 90 USD

Laagste 24 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Celldex Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

12 ratings

Buy

Hold

Sell

Gebaseerd op 12 analisten die aandelenratings hebben gegeven aan Celldex Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

18.91 / 20.63Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bearish.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.